We do now have drugs (Dononamab and Lecanemab) which show some benefit and one might consider whether these should be the placebo treatments against which new drugs are tested. Prof Paresh Malhotra , Group Leader at the UK Dementia Research Institute Care Research & Technology Centre and Head of the Division of Neurology at Imperial College London said: "These two linked trials show that, unfortunately, semaglutide appears to have no effect on progression in people with established Alzheimers disease, including people who have evidence of some damage to brain blood vessels
Diabetes 56 , 19511959 (2007)
What You'll Discover: What the latest research shows about GLP-1s and drinking How medications like semaglutide work on alcohol cravings Why naltrexone is still the first-line choice for most people When adding a GLP-1 might make sense Important safety considerations and side effects A practical step-by-step approach if you're considering GLP-1s If you've seen headlines about Ozempic, Wegovy, or other GLP-1 medications helping people drink less, you're not imagining it
Khrystyna Loza Weinan Du
Lemme GLP-1 Daily will be available to purchase on its website on September 16, 2024
What to do about it: Nothing
